HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
AXGN
Axogen Inc
Healthcare Medical Devices · Florida, USA · Reports in usd
Market Cap: $2.24B
Market Cap
$2.24B
Enterprise Val
$2.16B
P/E Ratio
-71.28
P/B Ratio
9.16
Trailing PEG (1Y)
-0.19
As Of
Apr 29, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$244.8M
Gross Margin75.16%
Profit Margin75.16%
Return on Equity-20.74%
Return on Assets-13.48%
Current Ratio7.10
Debt/Equity0.08
LT Debt/Equity0.08
Revenue Per Share1.18

Income Statement

Mar 31, 2026
Revenue$61.5M
Cost of Revenue$15.3M
Gross Profit$46.2M
R&D$7.5M
SG&A$41.5M
Operating Expenses$49.0M
Operating Income-$2.8M
Interest Expense$694.0K
Tax Expense$0.00
Net Income-$19.6M
EPS (Basic)$-0.38
EPS (Diluted)$-0.38
EBIT-$18.9M
EBITDA-$16.8M
Consolidated Income-$19.6M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$84.7M
Accounts Receivable$28.3M
Inventory$46.1M
Current Assets$184.7M
LT Investments$0.00
Property, Plant & Equipment$97.3M
Intangibles$7.3M
Non-Current Assets$104.8M
Total Assets$289.5M
Accounts Payable$23.9M
Current Debt$2.1M
Current Liabilities$26.0M
LT Debt$18.5M
Non-Current Liabilities$18.7M
Total Liabilities$44.7M
Total Debt$20.6M
Retained Earnings-$326.5M
Shareholder Equity$244.8M
Shares Outstanding51,897,682

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$1.6M
Investing Cash Flow-$16.0M
Financing Cash Flow$59.5M
CapEx-$2.8M
Free Cash Flow-$1.2M
Depreciation & Amort.$2.1M
Stock-Based Comp$6.8M
Acquisitions / Disposals$0.00
Investment Activity-$13.0M
Debt Issued/Repaid-$69.2M
Equity Issued/Repaid$137.5M
Dividends Paid$0.00
Net Change in Cash$45.1M
Data cached · Meta live · Daily live · Statements live · TTL 24h